期刊文献+

广东籍中老年人结直肠癌分子遗传学的致癌途径 被引量:1

Molecular genetic pathway of middle-aged and senile patients with colorectal carcinomas in Guangdong district
下载PDF
导出
摘要 目的 探讨中国广东地区中老年人 (年龄 >5 0岁 )结直肠癌 (CRC)的分子致癌途径。方法 应用流式细胞学和免疫组化方法检测 6 0例中老年人CRCs的DNA倍性及p5 3、hMSH2 和hMLH1蛋白表达 ,结合临床病理学资料 ,分析它们之间的相关性。结果 在 6 0例广东籍中老年大肠癌患者中 ,有 4 3例 (71 7% )为非整倍体DNA的含量 ,39例 (6 5 0 % )出现 p5 3蛋白过度表达 ,2例 (3 3% )丢失了hMSH2 或hMLH1蛋白。这组CRC的DNA倍性与p5 3蛋白表达有关 (χ2 =5 6 83,P =0 0 17) ,4 3例非整倍体DNA含量的CRC中 ,有 33例 (76 7% )呈 p5 3蛋白过度表达。丢失了hMSH2 或hMLH1蛋白的 2例CRC ,全部为二倍体的DNA含量 ,均呈 p5 3蛋白的正常表达 ,另外有 15例 (2 5 % )肿瘤既未出现非整倍体DNA含量 ,又未丢失hMSH2 或hMLH1蛋白 ,其中多数 (10 / 15 )表达正常的p5 3蛋白。结论 在中国广东地区中老年人CRC中 ,hMSH2 或hMLH1蛋白的丢失率低 ,多数 (71 7% ) Purpose To investigate the molecular genetic pathway of middle aged and senile (age>50) patients with colorectal carcinomas (CRC) in Guangdong, China. Methods Flow cytometry and immunohistochemistry were used to detect the status of DNA ploidy and expression of p53, hMSH 2 and hMLH 1 in 60 cases of middle aged and senile CRC from Guangdong province. The correlation between these molecular features was analyzed with their clinic pathologic data. Results Of the 60 middle aged and senile CRC studied, 43 cases of CRC (71 7%) had aneuploid DNA content, 39 cases (65 0%) showed over expression of p53, 2 cases (16 9%) lost mismatch repair protein, hMSH 2 or hMLH 1. In this group of CRC, the expression of p53 had a significant correlation with tumor's DNA ploidy (χ 2=5 683, P =0 017), where over expression of p53 were observed in most cases (33/43) of DNA aneuploid CRC. The two CRC with loss of hMSH 2 or hMLH 1 protein were all diploid DNA content and showed normal expression of p53. In addition, there were 15 cases (25%) of CRCs showing no loss of either MMR proteins and having a diploid or near diploid DNA content, and majority of them (10/15) expressed p53 protein normally. Conclusions In Guangdong, the incidence of loss of hMSH 2 or hMLH 1 protein in middle aged and senile CRC was low and majority (71 7%) of CRC were developed via the chromosomal instability pathway.
出处 《临床与实验病理学杂志》 CAS CSCD 2003年第1期59-62,共4页 Chinese Journal of Clinical and Experimental Pathology
基金 中华人民共和国学者MrsIvyWu研究基金资助 (No 1999~ 2 0 0 0No7)
关键词 广东 中老年人 结直肠癌 分子遗传学 致癌途径 CRC 病理学 免疫组织化学 流式细胞学 colorectal neoplasms mismatch repair gene flow cytometry immunohistochemistry
  • 相关文献

参考文献16

  • 1[1]Lengauer C, Kinzler KW, Vogelstein B. Genetic instability in colorectal cancers. Nature, 1997,386:623~7.
  • 2[2]Miyazaki M, Furuya T, Shiraki A,et al. The relationship of DNA ploidy to chromosomal instability in primary human colorectal cancers. Cancer Res, 1999, 59: 5283~5.
  • 3[3]De Angelis PM, Clausen OP, Schjolberg A,et al. Chromosomal gains and losses in primary colorectal carcinomas detected by CGH and their associations with tumour DNA ploidy, genotypes and phenotypes. Br J Cancer, 1999, 80: 526~35.
  • 4[4]Ionov Y, Peinado MA, Melkhosyan S,et al. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature,1993, 363: 558~61.
  • 5[5]Kruschewski M, Noske A, Haier J,et al. Is reduced expression of mismatch repair genes MLH1 and MSH2 in patients with sporadic colorectal cancer related to their prognosis? Clin Exp Metastasis, 2002, 19: 71~7.
  • 6[6]Fishel R, Lescoe MK, Rao MRS,et al. The human mutator gene homologue MSH2 and its association with hereditary non-polyposis colon cancer. Cell, 1993,75:1027~38.
  • 7[7]Leung SY, Yuen ST, Chan TL,et al. Chromosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation. Oncogene, 2000,19:4079~83.
  • 8谢丹,梁雪儿,曾薇芬,张萌,陈淑仪,袁兆灿,文剑明.青年人结直肠癌DNA错配修复基因表达和DNA倍性检测[J].中华病理学杂志,2000,29(6):412-415. 被引量:12
  • 9[9]Leung SY, Yuen ST, Chan TL, el al. Chomosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation. Oncogene, 2000, 19: 4079~83.
  • 10[10]Barletta A, Marzullo F, Pellecchia A,et al. DNA flow cytometry, p53 levels and proliferative cell nuclear antigen in human colon dysplastic, precancerous and cancerous tissues. Anticancer Res, 1998, 18: 1677~82.

二级参考文献4

  • 1Leung S Y,Cancer Res,1999年,59卷,159页
  • 2Yao J,Int J Cancer,1999年,80卷,667页
  • 3Chan T L,J Natl Cancer Inst,1999年,91卷,1221页
  • 4Liu B,Nature Med,1995年,1卷,348页

共引文献17

同被引文献14

  • 1李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 2He Q J, Zeng WF, Sham JST, et al. Recurrent genetic alterations in 26 colorectal carcinomas and 21 adenomas from Chinese patients.Cancer Genet Cytogenet, 2003, 144:112-118.
  • 3Al-Mulla F, Keith WN, Pickford IR, et al. Comparative genomic hybridization analysis of primary colorectal carcinomas and their synchronous metastases. Genes Chromosomes Cancer, 1999, 24:306-314.
  • 4Liao L, Kuang SQ, Yuan Y, et al. Molecular structure and biological function of the cancer-amplified nuclear receptor coactivator SRC-3/AIB1. J Steroid Biochem Mol Biol, 2003, 83:3-14.
  • 5Xie D, Zeng WF, Sham JST, et al. Heterogenous expression and association of β-Catenin, p16 and c-myc in multistage colorectal tumorigenesis and progression detected by tissue microarray. Int J cancer, 2003, 91:107-113.
  • 6Wang Y, Wu MC, Sham JST, et al. Prognostic significance of c-myc and AIB1 amplification in hepatocellular carcinoma. A broad survey using high-throughput tissue microarray. Cancer,2002, 95: 2346-2352.
  • 7Sakakura C, Hagiwara A, Yasuoka R, et al. Amplification and overexpression of the AIBl nuclear receptor co-activator gene in primary gastric cancers. Int J Cancer, 2000, 89: 217-223.
  • 8Anzick SL, Kononen RL, Walker RL, et al. AIB1, a steroid receptor coactivator amplification in breast and ovarian cancer.Science, 1997, 56: 965-968.
  • 9Bouras t, Melissa C, Venter DJ. Overexpression of the steroid receptor coactivator AIB1 in breast cancer correlates with absence of estrogen and progesterone receptors and positivity for p53 and Her2/neu. Cancer Res, 2001, 61: 903-907.
  • 10Grossman SR, perez M, Kung AL, et al. p300/MDM2 complexes participate in the MDM2-mediated p53 degradation. Mol cell,1998, 2: 405-415.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部